8 July 2024
Belluscura plc
("Belluscura", the "Company"}
Result of General Meeting
Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that at the General Meeting held earlier today both the resolutions put to the meeting were duly approved by Shareholders:
| Resolution | Votes for | % of shares voted | Votes against | % of shares voted |
| Resolution 1: To allot Shares re. Loan Notes. | 98,167,364 | 99.90% | 101,411 | 0.10% |
| Resolution 2*: To disapply Statutory | 98,167,364 | 99.90% | 101,411 | 0.10% |
The Company is pleased to confirm that, as announced on 2 July 2024, following Shareholder approval for the Resolutions as they relate to the issue of the Loan Note Placing, together with the recent Share Subscriptions for new ordinary shares, the Company has raised total gross proceeds of approximately £1.92 million.
In accordance with the terms of the Loan Note Placing Agreement, following passing of the Resolutions, the Placing Loan Notes will be issued on 9 July 2024.
The net proceeds of the Loan Note Placing and Share Subscriptions will be used for working capital purposes to support the growth in both the X-PLOR® and DISCOV-RTM portable oxygen concentrator devices sales, as set out in the Announcement and the Letter to Shareholders dated 2 July 2024.
Capitalised terms used in this announcement shall, unless defined in this announcement or unless the context provides otherwise, bear the same meaning ascribed to such terms in the Announcement made by the Company at 14:30 on 2 July 2024 and the letter to Shareholders dated 2 July 2024, which constituted a supplement to the Circular dated 14 June 2024.
For further information please contact:
|
Belluscura plc | Tel: +44 (0)20 3128 8100 |
| Adam Reynolds, Chairman Robert Rauker, Chief Executive Officer Simon Neicheril, Chief Financial Officer | |
| | |
| SPARK Advisory Partners Limited (Nomad) | Tel: +44 (0)20 3368 3550 |
| Neil Baldwin / Jade Bayat | |
| | |
| Dowgate Capital Limited (Broker) | Tel: +44 (0)20 3903 7715 |
| Russell Cook / Nicholas Chambers | |
| | |
| MHP (Financial PR & Investor Relations) | Tel: +44 (0)20 3128 8100 |
| Katie Hunt / Matthew Taylor | belluscura@mhpgroup.com |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.